Navigation Links
Media alert: ACMG 2011 Clinical Genetics Meeting -- press registration is now open
Date:2/16/2011

Health, science and genetics reporters are invited to register now for the American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting, March 16-20, 2011 at the Vancouver Convention Centre, Vancouver, BC, Canada. From Genomic Testing to Genomics and Cancer to The Future of Newborn Screening, the focus of the ACMG Meeting is on the practice of genetics and genomics in healthcare today and in the future. The conference will showcase the latest advances and breakthroughs in genetics research and its applications to medical practice and public health. The ACMG Annual Meeting attracts medical and scientific leaders from around the world who are working to apply research in genetics and the human genome to the diagnosis, management, treatment and prevention of genetic conditions and rare and common diseases.

Topics include:

  • Genomic Medicine in the Management and Prevention of Cancer
  • The Future of Newborn Screening
  • Global Perspectives on Screening for Jewish Genetic Diseases
  • The Exome Strategy for Gene Discovery and Medical Practice
  • New Insights in the Evaluation of Individuals With Intellectual Disability
  • Genetics Issues and Native Populations
  • Delivering Genomic Testing Results to Patients
  • Advances in Prenatal Diagnosis
  • Implications for Public Health: the Line Between Research and Clinical Genetic Testing
  • Translating Clinical Guideline for Family History Risk Assessment
  • Diagnostic Dilemmas Rare Knowns and Unknowns
  • Phenylketonuria (PKU)
  • Genetic Counseling
  • and many more

To see the complete program visit www.acmgmeeting.net.

New for 2011: The ACMG Foundation will present bicycles to children with rare genetic diseases from the Rare Disease Foundation of Vancouver in a heartwarming event on Saturday, March 19, 2011.

To receive a complimentary media registration, contact Kathy Beal, MBA at kbeal@acmg.net for the Press Registration Access


'/>"/>

Contact: Kathy Beal, MBA
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Related biology news :

1. Media advisory -- Partnering to Fight TB: The Role of a TB Vaccine PDP
2. Petrol stations pollute their immediate surroundings
3. SRNL demonstrating low-energy remediation with patented microbes
4. Oil spill symposium to convene scientists, media, policymakers and community leaders
5. Oceanic garbage patch not nearly as big as portrayed in media
6. GEN co-sponsors roundtable discussion on novel bioremediation techniques
7. Media alert: Agronomists, crop and soil scientists to convene in Long Beach
8. The elusive intermediary
9. AGU 2010 Fall Meeting: News media registration opens, book hotels now
10. Wall Street Communications Retained by iPharro Media
11. 35th ESMO Congress media alert
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: